| abstract |
The present disclosure relates to a crystalline salt form of the following compound (1) (also known as l-cordydamine or l-CDL), a preparation method thereof, a pharmaceutical composition thereof, and its use in the treatment of chronic pain, anxiety, insomnia, hyperlipidemia Use in a method for diabetes, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, metabolic syndrome, and the like. |